VT News - circadian rhythms
A collaborative research effort between the Bevan & Brown Lab and the Finkielstein Lab identifies an alternative mechanism to control circadian rhythms in normal cells that is driven by oncoproteins. The molecular interplay between cancer molecules and circadian rhythms can be used to tailor therapeutics in a more effective way. Complete findings of this study are published in the Science Signaling. Read the VT News feature article about the research here!